Aptinyx to Present at Upcoming Virtual Investor Conferences
16 juin 2020 08h37 HE
|
Aptinyx Inc.
EVANSTON, Ill., June 16, 2020 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and...
Le CN participera à une discussion informelle avec un représentant de BMO Marchés des capitaux, le 26 mars 2020
24 mars 2020 16h01 HE
|
Canadian National Railway
MONTRÉAL, 24 mars 2020 (GLOBE NEWSWIRE) -- Jean-Jacques Ruest, président-directeur général du CN, et Ghislain Houle, vice-président exécutif et chef de la direction financière du CN (TSX : CNR)...
CN to participate in a virtual fireside chat with BMO Capital Markets on March 26
24 mars 2020 16h01 HE
|
Canadian National Railway
MONTREAL, March 24, 2020 (GLOBE NEWSWIRE) -- JJ Ruest, President and Chief Executive Officer and Ghislain Houle, Executive Vice-President and Chief Financial Officer of CN (TSX: CNR) (NYSE: CNI),...
Sienna Biopharmaceuticals to Present at BMO Capital Markets Healthcare Conference
20 juin 2019 09h05 HE
|
Sienna Biopharmaceuticals, Inc.
WESTLAKE VILLAGE, Calif., June 20, 2019 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA), a clinical-stage biopharmaceutical company, today announced that Frederick C. Beddingfield...
VBI Vaccines Announces Pricing of $37.5 Million Public Offering
13 déc. 2018 09h05 HE
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Dec. 13, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and...
VBI Vaccines Announces Proposed Public Offering of Common Shares
12 déc. 2018 16h01 HE
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Dec. 12, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and...
Sienna Biopharmaceuticals to Present at BMO Capital Markets Healthcare Conference
06 déc. 2018 16h05 HE
|
Sienna Biopharmaceuticals, Inc.
WESTLAKE VILLAGE, Calif., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA), a clinical-stage medical dermatology and aesthetics company, today announced that Frederick...
Sienna Biopharmaceuticals to Present at BMO Capital Markets Healthcare Conference
11 déc. 2017 09h05 HE
|
Sienna Biopharmaceuticals, Inc.
WESTLAKE VILLAGE, Calif., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA) today announced that Frederick C. Beddingfield III, M.D., Ph.D., President and Chief...